Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC. Garrett Rappazzo, Laura M. Walker, Andrew S. Herbert et al.|Science|2021Cited by 394
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, Laura M. Walker, C. Garrett Rappazzo et al.|Science Immunology|2021Cited by 201
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C. Garrett Rappazzo, Laura M. Walker, Longping V. Tse et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 20
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyLisa E. Gralinski, John M. Dye, Longping V. Tse et al.|UNC Libraries|2021Cited by 0